Prudential Financial
WHWK

Prudential Financial’s Whitehawk Therapeutics WHWK Stock Holding History

Prudential Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,800
Closed -$38.8K – 2530
2025
Q1 		$38.8K Sell
21,800
-4,600
-17% -$12K ﹤0.01% 2217
2024
Q4 		$83.3K Hold
26,400
– – ﹤0.01% 2164
2024
Q3 		$54.4K Buy
+26,400
New +$42.7K ﹤0.01% 2639
2024
Q2 		– Sell
-21,355
Closed -$50K – 2813
2024
Q1 		$50K Buy
+21,355
New +$41.2K ﹤0.01% 2590

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prudential Financial's WHWK Position: Q2 2025 in Review

Prudential Financial sold out of Whitehawk Therapeutics (WHWK) in Q2 2025, closing a stake of 21,800 shares — an estimated $38.8K sold.

Prudential Financial first reported a position in WHWK in Q1 2024 and held it in 4 quarters. The position peaked at $83.3K in Q4 2024. 39 funds tracked by Wall St. Rank hold WHWK as of Q2 2025.

  • Prudential Financial reported no remaining Whitehawk Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 21,800 Whitehawk Therapeutics shares in Q2 2025, an estimated $38.8K.
  • Prudential Financial first reported a position in Whitehawk Therapeutics in Q1 2024 and held it in 4 quarters.
  • Prudential Financial's Whitehawk Therapeutics position peaked at $83.3K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.